Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Gilead Sciences (NQ:GILD)

123.95 +1.38 (+1.12%)
Streaming Delayed Price Updated: 3:31 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,558,816
Open 121.93
Bid (Size) 123.92 (200)
Ask (Size) 123.98 (600)
Prev. Close 122.58
Today's Range 121.72 - 124.10
52wk Range 86.08 - 124.61
Shares Outstanding 1,253,809,440
Dividend Yield 2.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns
The third-quarter 2025 earnings season, largely drawing to a close in early November, has proven to be a dynamic and often surprising period for investors. While a significant majority of S&P 500... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025.... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
+34.9%
+34.9%
1 Month
+9.1%
+9.1%
3 Month
+12.4%
+12.4%
6 Month
+25.3%
+25.3%
1 Year
+37.4%
+37.4%

More News

Read More
Gilead Sciences’s Q3 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
3 Cash-Rich Stocks With High Growth Potential Right Now
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Gilead Sciences Inc (NASDAQ:GILD) Appears as a Decent Value Stock
Via Chartmill
Moderna Earnings: What To Look For From MRNA
Via StockStory
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell Therapy Data at ASH 2025
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Inc (NASDAQ:GILD): A Dividend Stock with a Secure Payout and Strong Fundamentals
Via Chartmill
Amgen Earnings: What To Look For From AMGN
Via StockStory
Topics Artificial Intelligence
What To Expect From Myriad Genetics’s (MYGN) Q3 Earnings
Via StockStory
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
Via StockStory
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026
Via Benzinga
Topics Earnings
Gilead GILD Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Via Benzinga
GILD Q3 Deep Dive: HIV and Liver Disease Strength Offset Oncology Headwinds
Via StockStory
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)
From Gilead Sciences, Inc.
Via Business Wire
Meta Meltdown Sends Nasdaq Tumbling as Apple Shines After Hours
Via Chartmill
Topics Economy
Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares?
Via The Motley Fool
Topics Regulatory Compliance
Gilead Sciences Inc (NASDAQ:GILD) Reports Mixed Q3 2025 Results with Strong Earnings Beat and Cautious Revenue Outlook
Via Chartmill
Topics Earnings
Gilead Sciences (NASDAQ:GILD) Exceeds Q3 Expectations
Via StockStory
Covid Continues To Haunt Gilead. How One Drug Dinged Product Sales.
Via Investor's Business Daily

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 123.95
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 11/06/25 03:31 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 155.42B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 155B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.